Zymeworks Competitors and Similar CompaniesClear all
Gossamer Bio's competitors and similar companies include Foghorn Therapeutics.
 Gossamer Bio Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. | |
Founding Date | Founding Date 2015 | Founding Date 2016 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ Dublin 2, IE | Locations Cambridge, US HQ Cambridge, US |
Employees | Employees 11820% increase | Employees 1123% decrease |
Valuation ($) | Valuation ($) 208 m | Valuation ($) 452 m |
Financial | ||
Revenue (est.) | Revenue (est.) $48.5m (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) |
Net income | Net income ($170.4m) (FY, 2025) | Net income ($74.4m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 480m | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
Foghorn Therapeutics
HQ
Cambridge, US
Employees
112↓ 3% decrease
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company